Feline Leukemia Vaccine, KILLED VIRUS
The only vaccine with proven 2-year duration of immunity for feline leukemia virus (FeLV).1
Features and benefits
A quality core vaccine that protects against feline leukemia
- The only feline leukemia vaccine labeled to prevent persistent viremia for 2 years after vaccination2
- Superior Efficacy demonstrated vs. multiple FeLV vaccines 3,4
- The ONLY USDA-licensed 2-Year Duration of Immunity (DOI) FeLV vaccine 1,2 (Ideal for adherence to AAFP guidelines5)
- The ONLY vaccine to demonstrate efficacy over the long-term in a co-mingling study mimicking real life conditions1
- Proven safety profile-99% reaction-free in ongoing surveillance involving millions of doses1
- Available in combination with other Nobivac® feline vaccines to provide broader disease protection
- Optimal choice for all cats under 1 year of age and healthy indoor/outdoor cats of any age
- Approved for the vaccination of healthy cats as an aid in the prevention of lymphoid tumors caused by, and diseases associated with, feline leukemia virus (FeLV) infection
- Vaccination with this product prevents persistent viremia in cats exposed to virulent feline leukemia virus
- Recommended for use in healthy cats 9 weeks of age or older
- 99.99% reaction-free in ongoing surveillance involving millions of doses1
- Two-year duration of immunity means fewer vaccinations
Please see the product label for further safety information.
Administration and Dosage
For cats 9 weeks of age or older:
- Subcutaneous or intramuscular injection
- Initial 1-mL dose administered at 9 weeks of age or older
- Second 1-mL dose administered 3 to 4 weeks later
- Revaccination every 2 years with a single dose is recommended
For further information, including complete directions and warnings, please see the product label.
Product label(s) and MSDS
- Data on file, Merck Animal Health.
- Jirjis FF, Davis T, Lane J, et al. Protection against feline leukemia virus challenge for at least 2 years after vaccination with an inactivated feline leukemia virus vaccine. Vet Ther. 2010;11(2):E1–E6.
- Torres AN, O'Halloran KP, Larson LJ Schultz RD, Hoover EA. Feline leukemia virus immunity induced by whole inactivated virus vaccination Vet Immunol Immunopathol. 2010; 134 (1-2): 122-131.
- Patel M, Carritt K, Lane J, Jayappa H, Stahl M, Bourgeois M. Comparative efficacy of feline leukemia virus inactivated whole virus vaccine and canarypox viris-vectored vaccine during virulent FeLV challenge and immunosuppression. Clin Vaccine Immunol. 2015
- American Association of Feline Practitioners. AAFP 2013 feline vaccination advisory panel report. J Feline Med Surgery. 2013; 15:785-808